These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6077259)

  • 21. Cerebral vascular permeability in experimental allergic encephalomyelitis.
    Leibowitz S
    Neuropatol Pol; 1969; 7(3):303-9. PubMed ID: 5370322
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arginine esterase, kalnikreine and antitryptic activities in experimental allergic encephalomyelitis in dogs].
    Milyutin LV; Vilkov GA; Trapezontseva RA
    Vopr Med Khim; 1975; 21(3):254-8. PubMed ID: 1210103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte chemotactic activity in the cerebrospinal fluid from guinea pigs with chronic relapsing experimental allergic encephalomyelitis.
    Kirby JA; Suckling AJ; Rumsby MG
    Prog Clin Biol Res; 1984; 146():87-92. PubMed ID: 6718436
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of antilymphocytic serum on experimental allergic pertussis encephalomyelitis].
    Kanchurin AKh; Umerov ZhG
    Patol Fiziol Eksp Ter; 1972; 16(3):52-4. PubMed ID: 5051914
    [No Abstract]   [Full Text] [Related]  

  • 25. [Nucleic acids and nucleotides in experimental allergic encephalomyelitis. 3. Insertion of radioactive phosphate into fractions of cerebral nucleic acids in experimental allergic encephalomyelitis].
    Pechán I
    Biologia (Bratisl); 1966; 21(10):729-36. PubMed ID: 5955814
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunopathology of allergic encephalomyelitis.
    Brosnan CF; Wisniewski HM
    Prog Clin Biol Res; 1980; 39():379-90. PubMed ID: 7403188
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood-cerebrospinal fluid barrier permeability changes in guinea pigs inoculated for chronic relapsing experimental allergic encephalomyelitis or with adjuvant alone.
    Suckling AJ; Reiber H; Kirby JA; Rumsby MG
    Prog Clin Biol Res; 1984; 146():75-80. PubMed ID: 6718435
    [No Abstract]   [Full Text] [Related]  

  • 28. [Protective action of antioxidant preparations on the development of experimental allergic encephalomyelitis in guinea pigs].
    Kryzhanovskiĭ GN; Vilkov GA; Stepanenko EM
    Biull Eksp Biol Med; 1984 Nov; 98(11):527-30. PubMed ID: 6509167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The suppression of experimental allergic encephalomyelitis by heterologous antilymphocyte serum and antimetabolites].
    Fischer W; Müller J
    Acta Biol Med Ger; 1970; 25(1):197-200. PubMed ID: 5489676
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunomodulation of experimental allergic encephalomyelitis.
    Arnon R; Teitelbaum D
    Isr J Med Sci; 1993; 29(2-3):175-81. PubMed ID: 7682204
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental allergic encephalomyelitis (EAE) in two inbred guinea pigs: 1. Strain differences in developing chronic relapsing form of EAE.
    Fujiwara S; Ohtani S
    Jpn J Exp Med; 1980 Jun; 50(3):173-8. PubMed ID: 7001094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental allergic encephalomyelitis (EAE) in two inbred guinea pigs. II. Strain differences in susceptibility to passive transfer of EAE.
    Fujiwara S; Fujiwara M; Ohtani S
    Jpn J Exp Med; 1981 Feb; 51(1):17-20. PubMed ID: 7311076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response in guinea pigs at different stages of experimental allergic encephalomyelitis.
    Lassmann H; Karcher D; Kitz K; Lowenthal A; Noppe M; Verslegers W
    Prog Clin Biol Res; 1984; 146():171-8. PubMed ID: 6201887
    [No Abstract]   [Full Text] [Related]  

  • 34. On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis.
    Caspary EA; Hughes D; Field EJ
    Clin Exp Immunol; 1970 Sep; 7(3):395-400. PubMed ID: 5477936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies of experimental allergic encephalomyelitis in juvenile guinea pigs--chronic relapsing EAE (author's transl)].
    Hirayama M; Takayanagi T; Iida M; Sobue I
    Rinsho Shinkeigaku; 1980 Oct; 20(10):793-800. PubMed ID: 7460414
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of experimental allergic encephalomyelitis in guinea pigs by treatment with magnetophores].
    Zhitnukhin IuL; Zatepiakin IuS; Karasik OA
    Biull Eksp Biol Med; 1980 Dec; 90(12):713-5. PubMed ID: 7470609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITIES.
    BRANDRISS MW; SMITH JW; FRIEDMAN RM
    Ann N Y Acad Sci; 1965 Mar; 122():356-68. PubMed ID: 14313495
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrophysiological monitoring of experimental allergic neuritis and experimental allergic encephalomyelitis.
    Kraft GH; Slimp JC
    Prog Clin Biol Res; 1984; 146():449-53. PubMed ID: 6326161
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
    Tabira T; Itoyama Y; Kuroiwa Y
    Prog Clin Biol Res; 1984; 146():43-8. PubMed ID: 6201912
    [No Abstract]   [Full Text] [Related]  

  • 40. Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis.
    Nagai Y; Osanai T; Sakakibara K
    Jpn J Exp Med; 1982 Aug; 52(4):213-9. PubMed ID: 6983610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.